Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients.
- Published In:
- Biomedical reports, 24(2), 23 (2026)
- Authors:
- Rampengan, Derren D C H, Surya, Stevanus C, Tjandra, Kevin C, Lele, Juan A J M N, Rampengan, Starry H, Kadariswantiningsih, Ika N, Idrisov, Bulat, Idrisova, Alina, Empitu, Maulana A
- Database ID:
- RPEP-15969
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15969APA
Rampengan, Derren D C H; Surya, Stevanus C; Tjandra, Kevin C; Lele, Juan A J M N; Rampengan, Starry H; Kadariswantiningsih, Ika N; Idrisov, Bulat; Idrisova, Alina; Empitu, Maulana A. (2026). Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients.. Biomedical reports, 24(2), 23. https://doi.org/10.3892/br.2025.2096
MLA
Rampengan, Derren D C H, et al. "Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients.." Biomedical reports, 2026. https://doi.org/10.3892/br.2025.2096
RethinkPeptides
RethinkPeptides Research Database. "Cardiorenal safety and efficacy of angiotensin receptor-nepr..." RPEP-15969. Retrieved from https://rethinkpeptides.com/research/rampengan-2026-cardiorenal-safety-and-efficacy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.